Liminatus Pharma, Inc. Class A Common Stock (LIMN) is a publicly traded Healthcare sector company. As of September 20, 2026, LIMN trades at $3.56 with a market cap of $4.67M and a P/E ratio of -8.28. LIMN moved +6.78% today. Year to date, LIMN is -88.59%; over the trailing twelve months it is -94.60%. Its 52-week range spans $3.29 to $1,683.00. Rallies surfaces LIMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest LIMN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $3.56 |
| Market Cap | $4.67M |
| P/E Ratio | -8.28 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,683.00 |
| 52-Week Low | $3.29 |
| Volume | 18.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.21M |
| Gross Margin | 0.00% |
LIMN analyst coverage data. Average price target: $0.00.